Molecular Demolition

The ability of cells to degrade and rearrange extracellular matrix proteins is crucial for an organism's growth and development. Nearly 40 years ago, Jerome Gross and Charles Lapiere discovered that when tadpole tail fins resorb, their skin releases an enzyme that degrades native collagen triple helixes in the underlying support matrix.1 This enzyme, called collagenase, is present in a wide variety of vertebrates, invertebrates, and plants. Critical as it is, collagenase is just one member of a

Written byGregory Smutzer
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Critical as it is, collagenase is just one member of a large class of enzymes called metalloproteinases—protein-digesting enzymes whose catalytic activity depends on the presence of metal ions. Metalloproteinases can be inhibited by chelators, such as EDTA, which coordinate metal ions.2 Several zinc (Zn2+)-dependent endopeptidases exist, and are known collectively as matrix metalloproteinases (MMPs), or matricins.2 Both secreted and membrane-bound MMPs catalyze the breakdown of proteins located either on the cell's plasma membrane, or within the extracellular matrix (ECM).2

Researchers have come to recognize the critical role these enzymes play in regulating processes that range from development and morphogenesis to angiogenesis and metastasis. Biotech companies have stepped in to offer a wide range of reagents to facilitate the study of these diverse proteins.

A major task of MMPs in vivo is thought to be disruption of the ECM's structural organization during development, tissue resorption, and disease progression.2,4 This is accomplished ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies